ABBOTT INDIA
Back to Cashflow Statement
|
ABBOTT INDIA Last 5 Year Cash Flow from Operating Activities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Operating Activities | ₹1,012 Cr | ₹1,213 Cr | ₹893 Cr | ₹948 Cr | ₹727 Cr |
What is the latest Cash Flow from Operating Activities ratio of ABBOTT INDIA ?
| Year | Cash Flow from Operating Activities |
|---|---|
| Mar2025 | ₹1,012 Cr |
| Mar2024 | ₹1,213 Cr |
| Mar2023 | ₹893 Cr |
| Mar2022 | ₹948 Cr |
| Mar2021 | ₹727 Cr |
How is Cash Flow from Operating Activities of ABBOTT INDIA Trending?
| Years | Cash Flow from Operating Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,012 Cr | -16.57 | |
| Mar2024 | ₹1,213 Cr | 35.75 | |
| Mar2023 | ₹893 Cr | -5.73 | |
| Mar2022 | ₹948 Cr | 30.40 | |
| Mar2021 | ₹727 Cr | - | |
Compare Cash Flow from Operating Activities of peers of ABBOTT INDIA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ABBOTT INDIA | ₹58,923.9 Cr | 2% | 7.7% | -8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,591.0 Cr | 3.2% | 12.4% | 11.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹183,512.0 Cr | 1.8% | 11% | 10.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,850.0 Cr | 3.8% | 6.7% | 35.5% | Stock Analytics | |
| CIPLA | ₹113,884.0 Cr | 6.2% | 13.9% | -4.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,339.0 Cr | 5.4% | 8% | 9.1% | Stock Analytics | |
ABBOTT INDIA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ABBOTT INDIA | 2% |
7.7% |
-8% |
| SENSEX | 0.9% |
-3.6% |
-7.3% |
You may also like the below Video Courses